Ovation iX Iliac Stent Graft Iliac Limb (REF TV-IL1416160-J)Recalls & reported problems
Endologix LLC · The TriVascular® Ovation Prime® Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft is an endovascular device delivered via a small diameter catheter to treat abdominal aortic aneurysms (AAAs). The stent graft is designed to reline the diseased vasculature, providing an endovascular blood conduit for isolating the aneurysm from the high pressure flow of blood, thereby reducing the risk of rupture. The stent graft is a modular configuration comprised of an aortic body section, iliac limbs, and iliac extensions as required. The TriVascular Ovation Prime Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft includes, an Aortic Body Stent Graft and delivery catheter, Iliac Limb Stent Grafts and delivery catheters, Iliac Extension Stent Grafts and delivery catheters, as required, a Fill Polymer Kit, and an Autoinjector. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI M701TVIL1416160J1), received between Jul 10, 2019 and Aug 23, 2021 — classified as 3 injuries.
The most frequently reported specific device problem is “Complete Blockage” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Complete Blockage1
- Improper or Incorrect Procedure or Method1
- Insufficient Device Problem Information1
- Material Deformation1
- Off-Label Use1
Patient problems
- Failure of Implant1
- No Code Available1
- Stenosis1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryAug 23, 2021Complete Blockage; Complete Blockage
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE OVATION IX ABDOMINAL AORTIC ANEURYSM STENT GRAFT SYSTEM. APPROXIMATELY FOURTEEN (14) MONTHS POST INITIAL PROCEDURE THE PATIENT PRESENTED TO ROUTINE FOLLOW-UP WITH LEG PAIN. OCCLUSION CAUSED BY THROMBUS IN THE RIGHT OVATION IX ILIAC LIMB WAS IDENTIFIED. REINTERVENTION HAS BEEN SCHEDULED. THE PATIENT IS REPORTEDLY DOING WELL.
Patient problems: Failure of Implant
MAUDE report 12356417 ↗InjuryJul 30, 2019Off-Label Use; Improper or Incorrect Procedure or Method; Insufficient Device Problem Information; Off-Label Use; Improper or Incorrect Procedure or Method; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE OVATION IX ABDOMINAL AORTIC ANEURYSM STENT. APPROXIMATELY ONE (1) YEAR POST INITIAL PROCEDURE, A TYPE IB ENDOLEAK WAS DETECTED DURING ROUTINE FOLLOW-UP. HOWEVER, THE EXACT DATE OF EVENT IS UNKNOWN. THE PHYSICIAN ELECTED TO TREAT THE PATIENT BY IMPLANTING TWO (2) ADDITIONAL ILIAC LIMB OVATION IX DEVICES ON (B)(6) 2019. THE PATIENT IS REPORTEDLY DOING WELL AND THE LEAK WAS CONFIRMED RESOLVED POST RE-INTERVENTION. AS OF DATE, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: No Code Available
MAUDE report 8843148 ↗InjuryJul 10, 2019Material Deformation; Material Deformation
THE PATIENT WAS INITIALLY TREATED WITH AN OVATION IX ILIAC LIMB AND AFX2 SYSTEM, WHICH IS CURRENTLY OUTSIDE THE INDICATIONS FOR USE. THE PATIENT UNDERWENT A PREVIOUS RE-INTERVENTION FOR A REPORTED TYPE IB ENDOLEAK (REFERENCE 3008011247-2019-00067) WHERE AN ADDITIONAL OVATION IX LIMB WAS IMPLANTED. APPROXIMATELY 2-MONTHS POST RE-INTERVENTION FOR THE TYPE IB ENDOLEAK THE PATIENT PRESENTED FOR A ROUTINE FOLLOW-UP AND A COMPUTED TOMOGRAPHY WAS COMPLETED REVEALING A SUSPECTED KINK IN THE DEVICE AND NARROWING WITH DIMINISHED FLOW. THE PHYSICIAN TREATED THE PATIENT WITH A NON-ENDOGLOGIX WALL STENT SUCCESSFULLY RESOLVING THE KINK. THE PATIENT IS REPORTED AS STABLE AND WILL CONTINUE TO BE MONITORED.
Patient problems: Stenosis
MAUDE report 8777931 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page